Jens Voortman

DR.

20082019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 16 Article
  • 2 Meeting Abstract
  • 1 Research VU University Amsterdam, graduation VU University Amsterdam

Efficacy of BGJ398, a fibroblast growth factor receptor 1–3 inhibitor, in patients with previously treated advanced urothelial carcinoma with FGFR3 alterations

Pal, S. K., Rosenberg, J. E., Hoffman-Censits, J. H., Berger, R., Quinn, D. I., Galsky, M. D., Wolf, J., Dittrich, C., Keam, B., Delord, J-P., Schellens, J. H. M., Gravis, G., Medioni, J., Maroto, P., Sriuranpong, V., Charoentum, C., Burris, H. A., Grünwald, V., Petrylak, D., Vaishampayan, U. & 15 othersGez, E., de Giorgi, U., Lee, J-L., Voortman, J., Gupta, S., Sharma, S., Mortazavi, A., Vaughn, D. J., Isaacs, R., Parker, K., Chen, X., Yu, K., Porter, D., Porta, D. G. & Bajorin, D. F., 2018, In : Cancer discovery. 8, 7, p. 812-821

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Evaluation of several methodological challenges in circulating miRNA qPCR studies in patients with head and neck cancer

Poel, D., Buffart, T. E., Oosterling-Jansen, J., Verheul, H. M. & Voortman, J., 9 Mar 2018, In : Experimental & Molecular Medicine. 50, 3, p. e454

Research output: Contribution to journalArticleAcademicpeer-review

Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma

Wentink, M. Q., Verheul, H. M. W., Pal, S. K., George, S., Voortman, J., Danchaivijitr, P., Adelaiye, R., Poslinski, D., Groman, A., Hutson, A. & Pili, R., 1 Feb 2018, In : Clinical Genitourinary Cancer. 16, 1, p. e1-e9

Research output: Contribution to journalArticleAcademicpeer-review